Please use this identifier to cite or link to this item:
|Title:||Reduction of dihydroxyphenylacetic acid by a novel enzyme in the rat brain||Authors:||Xu, C.L.
|Issue Date:||26-Oct-1995||Citation:||Xu, C.L., Sim, M.K. (1995-10-26). Reduction of dihydroxyphenylacetic acid by a novel enzyme in the rat brain. Biochemical Pharmacology 50 (9) : 1333-1337. ScholarBank@NUS Repository.||Abstract:||A novel enzyme that converts dihydroxyphenylacetic acid (DOPAC) to dihydroxyphenylethanol (DOPET) was found to be present in the microdialysate of the rat brain. The enzyme, named DOPAC reductase, was inhibited by EDTA and stimulated by divalent cations like Zn2+, Mn2+, Co2+ and Cu2+. Its Km, pH optimum and temperature optimum were found to be 32 ± 2 μM, 7.5 and 40 °, respectively. The equivalent acid metabolite of noradrenaline, 3,4-dihydroxymandelic acid, and the methoxylated acids of both noradrenaline and dopamine, 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid, were found not to be substrates of DOPAC reductase. Thus, DOPAC reductase may be an enzyme that is specifically involved in the one-step conversion of DOPAC to DOPET in the central metabolism of dopamine. © 1995.||Source Title:||Biochemical Pharmacology||URI:||http://scholarbank.nus.edu.sg/handle/10635/133959||ISSN:||00062952|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Nov 8, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.